Could a new test that measures the cardiovascular biomarker amino terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) using dried blood samples be used to identify neonates born with congenital heart disease (CHD)? This evidence concerns the gene NPPB and coronary artery disorder.